disease-modifying antirheumatic drug(redirected from Disease-modulating arthritis drug)
Also found in: Wikipedia.
disease-modifying antirheumatic drug (DMARD)
a classification of antirheumatic agents referring to their ability to modify the course of disease, as opposed to simply treating symptoms such as inflammation and pain. Agents in this group include auranofin, azathioprine, cycloSPORINE, gold salts, hydroxychloroquine, leflunomide, methotrexate, D-penicillamine, and sulfasalazine.
disease-modifying antirheumatic drugDMARD Rheumatology Any agent–eg, azathioprine, gold, cyclophosphamide, hydroxychloroquin, and MTX–which slows the rate of joint destruction in rheumatoid arthritis
disease-modifying antirheumatic drugAbbreviation: DMARD
A drug that is used to treat rheumatoid arthritis and acts more slowly but more effectively than nonsteroidal anti-inflammatory drugs. Such drugs include hydroxychloroquine, methotrexate, and tumor necrosis factor inhibitors.Synonym: slow-acting antirheumatic drug
See also: drug